Codebreaker

3X Genetics

This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.

Cassidy Bio

This company develops an AI foundation model to design gene editing therapies and prediction tools for pharmaceutical partners and researchers.

Nostos Genomics

The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.

VUS Genetics

This company develops high-throughput functional assays for drug developers to classify gene variants and improve patient stratification in oncology and rare disease clinical trials.

Elegen

The company manufactures synthetic DNA using cell-free technology for biopharmaceutical and healthcare customers to develop vaccines and genetic medicines.

Genetic Sequencing

This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.

Theorema

This company builds causal disease models for pharmaceutical and biotech firms to identify drug targets and find new indications for existing assets.